To download the latest issue
Oct 9th, 2013
Oxford Nanopore announces £40 million ($64 million) fundraising
Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has raised £40 million in new funding through a private placement of ordinary shares.
The investment was received from new and existing investors in the US, UK and mainland Europe. New investors include Odey Asset Management.
Funds will be used to further develop the Company's commercial and manufacturing infrastructure, continue innovative research and development in nanopore sensing and for various corporate objectives including the building and defence of the Company's broad intellectual property portfolio.
This transaction brings the total funds raised by Oxford Nanopore since its foundation in 2005 to £145 million.
Oxford Nanopore has licensed or owns more than 350 patents and patent applications that relate to many aspects of nanopore sensing from protein nanopores to solid state nanopores and for the analysis of DNA, proteins and other molecules. This includes the use of functionalised solid-state nanopores for molecular characterisation, methods of fabricating solid-state nanopores and modifications of solid-state nanopores to adjust sensitivity or other parameters.
More MEDTECH news